Universiteit Utrecht
World Health Organization
Home
People
Publications
Events
News
About
Utrecht/WHO Collaborating Centre for
Pharmaceutical Policy and Regulation
PhD Theses
Pharmaceutical Policy
Publications
Underneath you can find the PhD theses of our professional PhDs who completed their PhD projects:
Pieter Stolk
(2008) -From new molecules to leads for innovation – studies on the post-innovation learning cycle for pharmaceuticals
Harald Heemstra
(2010) – From research on rare diseases to new orphan drug development
Marjolein Willemen
(2011) – The context of medicines’ use in benefit-risk evaluation
Hans Ebbers
(2011) – Biopharmaceuticals as Challenges to the Regulatory System
Thijs Giezen
(2011) – Risk management of biologicals: a regulatory and clinical perspective
Brenda Waning
(2012) – Innovative approaches for pharmaceutical policy research in developing countries
Jarno Hoekman
(2012) – Science in an age of globalisation: the geography of research collaboration and its effect on scientific publishing
Alexandra Cameron
(2013) – Understanding access to medicines in low and middle-income countries through the use of price and availability indicators
Michelle Putzeist
(2013) – Marketing authorization of new medicines in the EU: towards…
Giovanni Tafuri
(2013) – Exploring the regulatory decision making process for medicines
Joëlle Hoebert
(2013) – Cross-country variation in medicines use; a pharmaceutical system perspective
Christine Leopold
(2014) – Pharmaceutical policy analysis – A European perspective on pricing and reimbursement in challenging times
Verica Ivanovska
(2014) – Pediatric drug formulations: a review of challenges and progress
Francisco Hernandez
(2015) – Subfilter Scale Modelling for Large Eddy Simulation of Lean Hydrogen-Enriched Turbulent Premixed Combustion
Peter Stephens
(2015) – Access to Medicines: Common problems, Common solutions?
Niels Vermeer
(2015) – Pharmacovigilance of biologicals: dynamics in post-approval safety learning
Luther Gwaza
(2016) – Adjusted indirect treatment comparisons of bioequivalence studies
Sarah Kleijnen
(2016) – Harmonising relative effectiveness assessments of medicines in Europe
Joris Langedijk
(2016) – Continuous innovation in the drug life cycle
Tom Achoki
(2016) – Revisiting Health System Performance Assessment in Africa
Ruben Duijnhoven
(2016) – Assessing long-term and rare adverse effects of medicines
Rianne van den Ham
(2016) – Benefits and risks for the individual, anticoagulation for patients with atrial fibrillation
Yared Santa Ana Telez
(2016) – Evaluating pharmaceutical policies using cross-national comparisons and time series analysis
Yaser Bazerghani
(2016) – Access to essential medicines in low and middle income countries
Daniel Ankrah
(2017) – Pharmaceutical policies and access to medicines : a hospital-pharmacy perspective from Ghana
Sander van den Bogert
(2017) – Trials & Tribulations: Studies on the fate, transparency and efficiency of clinical drug trials
Iga Lipska
(2017) – Variation in Health Technology Assessment of new medicines: processes and outcomes
Evans Sagwa
(2017) – Optimizing the Safety of Multidrug-resistant Tuberculosis Therapy in Namibia
Raymond Tetteh
(2018) – The Use and Safety of Antiretroviral Medicines: Lessons from Ghana
Teresa Alves
(2018) – Patient Perspectives in Pharmaceutical Policy: Information and influence in the diffusion of new medicines
Publications
PhD Theses
Journal Publications
Reports